Arkema SA (OTCMKTS:ARKAY) Receives Consensus Rating of “Reduce” from Analysts

Shares of Arkema SA (OTCMKTS:ARKAYGet Free Report) have been assigned a consensus recommendation of “Reduce” from the nine research firms that are presently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, six have given a hold recommendation and one has issued a buy recommendation on the company.

A number of analysts recently issued reports on ARKAY shares. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Arkema in a research report on Thursday, April 9th. Berenberg Bank downgraded Arkema from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 20th. Kepler Capital Markets downgraded Arkema from a “hold” rating to a “strong sell” rating in a research report on Thursday, May 7th. Sanford C. Bernstein raised Arkema from a “strong sell” rating to a “hold” rating in a research report on Monday, April 20th. Finally, Zacks Research raised Arkema from a “strong sell” rating to a “hold” rating in a research report on Monday, May 4th.

Read Our Latest Research Report on ARKAY

Arkema Stock Up 0.5%

Shares of ARKAY opened at $66.80 on Wednesday. The stock has a fifty day simple moving average of $70.94 and a two-hundred day simple moving average of $66.10. The company has a quick ratio of 1.64, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. The company has a market capitalization of $5.08 billion, a PE ratio of 267.21 and a beta of 0.84. Arkema has a 52-week low of $56.28 and a 52-week high of $79.36.

Arkema (OTCMKTS:ARKAYGet Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The basic materials company reported $1.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.10. The firm had revenue of $2.57 billion during the quarter, compared to the consensus estimate of $2.52 billion. Arkema had a return on equity of 4.06% and a net margin of 0.46%. As a group, equities analysts forecast that Arkema will post 3.89 EPS for the current year.

Arkema Company Profile

(Get Free Report)

Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.

Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.

Further Reading

Analyst Recommendations for Arkema (OTCMKTS:ARKAY)

Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.